The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_4633	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	50% cell viability after 2 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4634	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	30% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4635	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	35% cell viability after 6 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4636	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	30% cell viability after 8 days	No	No	NA	No response	NA	NA	NA	NA	27093696